longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Infusystem

INFU

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 30.38, within the reasonable range, cheaper than 40.23% of the time in the past 1 years, and the industry ranks 18/74, the industry Median --.

30.38xP/E
$13.03Stock price
$0.43Earnings per share
30.38xP/E
Stock price$13.03Earnings per share$0.43

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
29.19x
Typical range
24.85x–33.87x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
08162432

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BTSGUSBrightSpring Health Services
30.11x86.70%$11.02B
CRVLUSCorVel
32.62x--$3.76B
GRDNUSGuardian Pharmacy Services
39.10x56.67%$2.58B
PNTGUSPennant
43.80x35.12%$1.42B
INFUUSInfusystem
30.38x37.64%$259.52M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.